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In order to tra ce the origins of age-de pendent diseases 
to the cellular level, w e studied cultured human fibro-
blasts from subjects with 3 discrete inherited disorders 
and normal controls of various ages_ Skin fibroblast s 
from subjects with progeria and W erner syndrome had 
a modera te to severe r eduction in growth capacity, 
whereas cells from subjects with diabete s m ellitus had a 
more subtle growth impairment. There was a decreased 
response of progeric fibrobla sts to insulin-like hor-
mones, and in normal cells the response decreased as a 
function of the passage level and donor age. Tissue fac-
tor, a procoagulant, was more abundant in progeric and 
W erner fibroblasts. An understanding of fibroblast ag-
ing in vitro may h elp us explain various concomitant 
phenomena of organismic a ging such a s diabe te s m elli-
tus , cell dropout, impaired hormone r esponsiveness, and 
increased atherothrombosis . 
Numerous pathologic conditions accompa ny biological aging, 
and these include diabetes mellitus, a therosclerosis, a nd cancer 
[1]. The studies perform ed in our la bora tory have primarily 
involved an in vitro approach to inherited human disorders of 
premature aging tha t featme early onset and accelerated pro-
gression of these age-associated conditions [2,3]. 
In this r eport I progress along a hiera rchy from specific 
clinical ent ities to biochemical lesions in cells . I describe the 
growth of cultured fibroblas ts, the r esponse of fibroblasts to 
hor mones with insulin-like activity (ILA) , and finally some 
characteristics of intracellular enzymes and clotting factors. 
Alterat ions occur in all of these cellular factors as a function of 
d onor age, whether in the usual sense of chronological age or in 
the sense of the advanced physiological aging of specific inher-
ited disorders. Altera tions also occur as a function of culture 
passage level, i.e ., aging in vitro [4]. 
HUTCHINSON-GILFORD AND WERNER SYNDROMES 
We have sought to exploit these 2 disorders in the study of 
biological aging for one major reason. Because each appears t o 
involve a single gene (perhaps autosoma l recessive in the 
Hutchinson-Gilford [progeria] syndrome and very likely auto-
somal recessive in the Werner syndrome), all clinical manifes-
tations of prematme aging should ultimately be traced to a 
single faulty gene product, i.e., a prote in, and we should be 
able to distinguish between the primary disordered gene and 
the ensuing secondary phenomena. These disorders have been 
described in detail, and contrasts have been made to normal 
. biological aging [2,5,6]. In brief, progeria is manifested dming 
infancy as severely stunted growth, premature aged appear ance, 
early onset of mesenchym al. tissu-e---degenera tion, greying and 
loss of hair, and severe resis tance to t he hypoglycemic effect of 
exogenous insulin. Werner syndrome features similar problems 
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a lt hough the onset age is characteristically beyond puberty. 
Additionally, over t dia betes of an insulin-resistant form is com-
mon in Werner syndrome, as are lent icul ar catar acts, skin 
ulcers, and severe osteoporosis. Despite these clear-cut differ-
ences, each disorder usually terminates wit h widespread ath-
erosclerosis that ult imately leads to premature death through 
coronary or cerebrovascular occlusion. Wit h Werner syndrom e 
t here is also a peculia rly high incidence of sarcomatous tumors. 
DIABETES M ELLITUS 
In the more common forms of dia betes melli tus not associated 
with specific genetic syndrom es, there is a decreased life ex-
pectancy even with insulin therapy [2,3,7]. T he genetics of 
dia betes remains controversial , but it is becoming evident that 
this is a heterogeneous disease complex t hat involves many 
genetic and environmental variables, that is, mul tifactorial in-
herita nce. . 
CURTAILED REPLICATIVE LIFE SPAN OF 
FIBROBLAST S 
Cultured skin fibroblasts from both progeria and Werner 
syndrome pat ients have shown reduced replicative life spans 
(Ta ble I) , although more h eterogeneous growth performa nces 
have been observed in fibroblasts from progeria patients. T he 
normal mean of 50.3 mean popula tion doublings (M PD) r ep-
resents a lar ge range in growth capacit ies because of th e inverse 
correla tion that exists between donor age a nd cult ure life span 
[8-12]. Progeria occurs in younger individuals, and their fibro-
blasts should in fa irness be compared to age-matched control 
fibroblasts tha t perform somewhat better than the normal 
mean. Conversely, the more uniform growth depression appar-
ent in Werner fibroblasts is due t o t heii- more advanced chron-
ological and physiological age but m ay also be related to t he 
fact tha t biopsy specimens have been t aken from these individ-
uals in la ter disease stages. 
In the common forms of dia betes m ellitus t here is also 
reduced growth of cultured cells , but this phenomenon is m ore 
subtle. In coded studies on cultures derived from juvenile-onset 
diabe tics, maturity -onset diabetics, and people genetically pre-
disposed to the disease (both parents overtly diabetic ["predi-
abe tic"]) , there was an overall impairment of growth that began 
at t he stage of primluy cultures (Table II). In th ese sam e 3 
groups bearing the dia betic genotype, growt h was also impaired 
in secondary cultures (Fig 1) . The growth advantage of normal 
cultmes was relatively small and only reached statistical signif-
icance in some cases. However , the trends were reproducible 
over the fIrst 7 subcult m es, an indication that the dia betic 
growth deficit is a persist ent heritable characteristic. The effect 
of advancing cultm e age was !Seen in fibroblasts from these 3 
groups and in those from controls as the lengthening interval 
required to atta in confluence. 
The onset of senescence also occurred earlier in cult ures 
emana ting from prediabetic and diabetic donors (Table III) . 
The r eplicative life span (Ta ble III) was marginally longer in 
normal cells, and th ere was an apparent downward progression 
through predia betic a nd diabetic cultures. These differences, 
however , did not reach sta tis tical significance. I must emphasize 
that control cultures were derived from normal individuals who 
were stringently select ed on the basis of negative family histo-
ries for diabetes a nd on the basis of repeatedly normal r esults 
of glucose tolerance t ests . Two fmt her points ar e worth empha-
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TABLE 1. R eplicative life span of cultured fib roblasts from shin of 
subjects with progeria, Werner syndrome, and controls" 
Donor group Donor age (yr) Replicative life span (mean population 
doublings) 
Controls 
85 subjects newborn-75 years 50.3 ± 2.1 c 
Progeria/ 
Case 1 2.5 36 
Case 2 6 52 
Case 3 9 6 
Case 4 9 37 
Werner syndrome" 
Case 1 37 12 
Case 2 43 5 
Case 3 46 12 
Case 4 48 8 
Case 5 49 6 
" Data from reference 2. 
"There are several reports not included here of primary growth 
failure in progeria and Werner cul tures. 
r Mean ± SO. 
TABLE n. Intensity of outgrowth at late stages of primary culture" 
Donor b'roup 
Normal 
Prediabetic . 
Juvenile-onset diabetics 
Maturity-onset diabetics 
First plateau" (days) 
13.24 ± 0.63 
15.45 ± 0.69 
17.41 ± 0.84 
18.21 ± 1.14 
" Mean ± SE. Normal versus prediabetics, p < .05; normal versus 
juvenile-onset diabetics, p < .01; normal versus maturity-onset dia-
betics, p < .01. From reference 13. 
/, Earl iest time in days at which the maximum percentage of ex-
planted skin fragments showed growth. 
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FIG 1. Growth vigor of secondary fibroblast cultures measured as 
the time required to attain confluence after subculture. A shorter 
interval indicates greater vigor. Data are the means ± SEM. Statisti-
cally signi1icant differences versus normal a1'e * p < .05 and I p < .01. 
JOD = juvenile-onset diabetes; MDD = maturity-onset diabetes. From 
reference 13, reproduced with permission of The Rockefeller University 
Press. 
sizing. First, the overall growth of a cu lture is sustained by the 
most vigorous sUbpopulation of cells. Thus, th ese diabetic cul-
tures may already have h ad a greater fraction of senescent cells 
t hat were unresponsive to growth factors in the cul ture medium 
even though overall capacity to proliferate appeared only mar-
ginally impaired. In fact, t here is direct evidence for such 
heterogeneity in all 3 diabetic gro~ps discussed here [13] a nd in 
normal individuals [14]. Second, during establishment of cul-
tures, only th e most vigorous ceUs grow out of primary skin 
explants, and we chose to propagate secondary cul tures using 
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only the best outgrowths from several replicate dishes. Hence, 
it is likely that we introduced some bias against the demonstra-
tion of impaired fibroblast growth in vitro. It may be that a 
greater proportion of diabetic and prediabetic cells are senes-
cent in vivo. 
DECREASED RESPONSE OF CELLS TO INSULIN-
LIKE ACTIVITY DURING AGING IN VIVO AND IN 
VITRO 
Many attempts to study the effects of insulin in cultured 
human fibroblasts have been hampered by both sluggish re-
sponses and th e need to carry out tedious manipulations, e .g., 
serum starvation for 24 hr. These problems ar e probably related 
to the fact that insulin, in contrast to the many insulin-like 
polypeptides recently elucidated, is not the prime stimulating 
h ormone for fibroblasts [15]. A number of these growth factors 
share sequence h emology with insulin and have overlapping 
receptor reactivity [16]. Recent work in our laboratory [17,18] 
has shown that fibroblasts derived from young normal donors 
need relatively small amounts of ILA for the stimulation of 
DNA synth esis (Fig 2). The concentration of ILA required to 
TABLE III. Onset of senescence and replicative life span of cultured 
shin fibroblasts from normal, prediabetic, ju.venile·onset, and 
ma.turity-onset diabetic donors" 
Donor group 
Normal 
Prediabetic 
Juvenile-onset dia-
betics 
Maturity-onset di-
abetics 
Onset of senescence 
(MPD to first refeed ing) 
23.9 ± 2.9/' 
12.6 ± 3.1 
12.4 ± 3.8 
13.5 ± 5.2 
Replicative life span 
(MPD to termination) 
52.5 ± 2.2'" 
47.8 ± 2.4 
47.1 ± 3.0 
46.4 ± 4.0 
"Mean ± SE mean population doublings (MPD). Data are from 
reference 13. 
" Normal versus prediabetics, p < .05; normal versus juvenile-onset 
diabetics, p < .05. 
'" Differences between normal and other 3 groups: not significant. 
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FIG 2. Effect of donor age and progeria on the concentration of 
insulin-like activity ([LA) required to stimulate DNA synthesis to 50 0 
and 95% of the maximum response. DNA synthesis was measured by 
"H·thymidine incorporation into trichloracetic-acid-precipi table mate-
rial. The age range of controls is given below the bars. The progeria 
subject was 9 yr old. From reference 18 and C. B. Harley et aI, in 
preparation. 
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FIG 3. Effect of aging in vitro on maximum insulin-like activity 
(ILA) stimulation of 2-deoxyglucose uptake. Fibroblasts were allowed 
to grow to conflu ence. They were then rinsed and incubated for 3 hI' 
with a maximal stimulating concentra tion of ILA (4 ng equivalents/ ml 
wi th respect to a radioreceptor assay for insulin [ref 48]) or normal 
saline (basal) and then incubated in medium without glucose containing 
"H-2-deoxyglucose. After a series of times up to 10 min, the rates of 
radioactivity accumulation in acid-insoluble material were determined, 
and the ratio of ILA-stimulated uptake to basal uptake was calculated. 
From reference 18 and C. B. Harley et ai, in preparation. 
produce 50% of the maximum stimulation was only slightly 
greater in the oldest normal donors. On the other hand, the ILA 
concentration required to produce 95% of the maximum stim-
ulation was substant ially greater in this older group. Progeria 
cells are clearly unique since they require even greater amounts 
of ILA for stimulation at both the 50% a nd 95% levels than do 
cells of the oldest group of controls. A similar increase in ILAr,o 
and ILA[)!; also occms as a function of the passage level 
[17,18]. 
Using 2-deoxyglucose, an analogue of glucose (the most com-
monly measmed parameter in diabetes), we also found that t he 
ratio of maximum hormone-stimulated uptake to basal uptake 
was consistently decreased in all age groups as cultures tra-
versed the in vitro life span (Fig 3). Progeria cultmes showed 
an even greater r eduction in the stimulat ion ratio, but the 
difference in these cells between early and late passage was . 
small probably as a result of the restricted replicative life span. 
This lower stimulation ratio in progeria is in part attributable 
to a higher basal level of uptake [17,18]. The same effect has 
been observed in late-passage normal fibroblasts (Table IV) , 
and it appears that aged cells are relatively unable to "down-
regulate" their carbohydrate metabolism [18] and protein me-
t abolism (C. B. Harley et aI, in preparation). Thus, the basal 
uptake of glucose is higher, the maximum stimulation by ILA 
is lower, and a narrow excursion results. 
The reasons for this impaired responsiveness to ILA may 
reside anywhere in the sequence from the hormone receptor on 
the cell surface, to the purine cyclase systems in the plasma 
membrane, to the intracellular enzymatic machinery. Although 
we have no data on ILA receptors in cultmed fibroblasts, our 
studies have shown th at the insulin receptor is altered as a 
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function of age [20,21]. With the many similarities between 
insulin and ILA polypeptides, we speculate that altered ILA 
receptors may be a prominent factor in the blunted response of 
aged cells to ILA. Indeed, a recent r eport by Villee and Powers 
[22] has confu'med that skin fibroblasts from the same progeric 
patient we studied were resistant to insulin stimulation of amino 
acid and glucose incorporation into proteins and glycogen, 
respectively. 
AGE-DEPENDENT CHANGES IN INTRACELLULAR 
ENZYMES 
Impaired hormone responsiveness of cells may also be related 
to altered enzymatic machinery distal to the membrane recep-
tor. Although the findings for normal cultures aging in vitro 
have been controversial [23- 26], the results in progeria and 
Werner syndrome have been more clear-cut; rather consistent 
and relatively large heat-labile subfractions have been found in 
cultured fibroblasts of both progeria and Werner syndrome 
patients [27-30] and in circulating erythrocytes [31,32]. Obser-
vation of erythrocytes (Table V) freshly removed from the 
circulation has substantiated the idea that heat-labile enzymes 
in vitro reflect a valid biological phenomenon. The exact struc-
tmal basis for these alterations remains unknown, but we ru'e 
exploring various possibili t ies [33,34]. These include primary 
changes in the amino acid sequence of enzymes introduced at 
the level of messenger RNA translation, posttranslational al-
terations, and problems at the level of DNA or RNA metabo-
TABLE IV. Glucose con.5U1ned during 2- day intervals of growth to 
confluence in early- and late-passage cu.ltures (nanograms per cell)" 
Passage level 
Days Ratio of LI E 
Early Late 
0-2 6.1 16.0 2.6 
2- 4 2.3 6.0 2.6 
4-6 1.5 3.6 2.4 
6-8 1.3 2.6 2.0 
8-10 0.9 2.3 2.6 
10-12 0.6 2.0 3.3 
" Early- and late-passage cultures became conl1uent on days 6 and 
10, respectively. From reference 19. 
Abbreviation: L/E = late/early. 
TABLE V. Fraction of heat-labile enzymes in circulating 
erythrocytes" 
En:r.yme Heat-labile fraction" p valu er 
Progeria family 
Proband 
G6PD 22.26 ± 4.33 (5) .001 
6PGD 22.31 ± 8.09 (3) .005 
HGPRT 21.20 ± 1.84 (2) .05 
Mother 
G6PD 13.83 ± 3.79 (5) .001 
6PGD 9.13 ± 2.58 (2) .1 
HGPRT 19.69 ± 4.04 (3) .1 
Father 
G6PD 11.57 ± 1.36 (4) .001 
6PGD 9.69 ± 1.84 (2) .05 
HGPRT 28.05 ± 4.76 (3) .02 
Controls 
G6PD 3.43 ± 0.75 (8) 
6PGD 5.05 ± 1.40 (6) 
HGPRT 11.68 ± 4.41 (5) 
" Data are mean percent ± SEM. Data are from reference 32. 
"Numbers of experiments on separate blood samples are indicated 
in pru·entheses. 
"Significance of difference: family member versus controls; p < 
values are shown. 
Abbreviations: G6PD = glucose-6-phosphate dehydrogenase; 6PGD 
= 6-phosphogluconate dehydrogenase; HGPRT = hypoxanthine-gua-
nine phosphoribosyl transferase. 
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lism. Whatever the basis may be, enzymes affected in this way 
probably are less efficient catalytically in response to substrates, 
cofactors, and other small molecules concerned with regulation. 
These facts, combined with the results of earlier studies on 
cycJjc AMP [35-37J, indicate that alterations may occur at each 
step in the sequence from hormone receptor tlU'ough the cycHc 
nucleotide system and intracellular enzymes. In concert, all of 
these steps may be responsible for the blunted response of aging 
ceUs to hormones like insulin . An exciting recent report by 
Kobayashi et al [38] indicates that in Donohue syndrome (i.e., 
leprechaunism, which shares many features, such as severe 
growth stunting and insulin resistance, with progeria) insulin 
binrung is normal but the impaired responsiveness of cultured 
cells with respect to glucose uptake resides in a postreceptor 
defect, perhaps in the cell membrane or the distal enzymatic 
machinery. 
INCREASED TISSUE FACTOR CONTENT IN 
PROGERIA AND WERNER FIBROBLASTS 
The complex scheme of blood coagulation can be reduced to 
2 major pathways, the intrinsic and extrinsic [39]. Both can be 
triggered by initial interaction with components of the cell wall 
in vivo, but each can be analyzed individually in test tubes. In 
brief, the intrinsic system involves circulating protein factors, 
primarily factor XII (Hageman factor), and factor VIII (anti-
hemophilic factor) . The extrinsic system involves tissue factor 
and factor VII, which "short-circuits" many of the reactions in 
the intrinsic system that result in t lu'ombin production. This 
reaction in tum commences the polymerization of fibrinogen to 
the mature fibrin clot. 
We observed that tissue factor activity was consistently 
higher in cultured fibroblasts from progeria and Werner sub-
jects (Table VI) and ranged from 23 units to 137 units. The site 
of the skjn biopsy did not seem to influence this activity. 
Normal control cells showed no effect of chronological age over 
the span of 5 to 75 years, and the effect of in vitro passage 
appeared to increase the mean tissue factor level (Table VI). 
This increase was not statistically significant. 
Fibroblast tissue factor was specific, that is, through factor 
VII, for the extrinsic clotting mechanism. Thus, when cells were 
incubated prior to assay with specific immunoglobulins directed 
against purified placental tissue factor, both normal and pro-
geria cells demonstrated progressive prolongation of the clotting 
time; prolongation did not occur after treatment with preim-
mune globulins or normal saline. Cells disrupted by sonication 
showed an approximately 5-fold increase in tissue factor activity 
. TABJ~E VI. T,:ssue factor activity of cultured skin fibroblasts" 
Donor group 
Con trol 
Early passage 
Late passage 
Progeria 
Donor age (yr) 
range 5-75 
Case 1 2.5 
Case 2 9 
Case 3 9 
Tissue factor (units) 
5.06 ± 3.84" 
7.96 ± 6.84 
42 
126 
Anterior forearm 23 
AnteriOl' thigh 47 
Left calf 137 
High t calf 109 
Werner syndrome 56 46 
a ALI cultures were derived from the skin of the anterior forearms of 
10 normal donors Iwd of persons with progeria and We/'ller syndrome, 
except where otherwise indicated. From reference 40. Early-passage 
normal ce lls were assayed in the fil'st haLr of their replicative life span, 
which ranged from 48 to 75 mean popu lation doublings (MPD) with 
late-passage cells at 3 to 9 MPD before termination. Progeria ce Lis 
(replicative life spans, range 21 to 40 MPD) were assayed with 9 to 30 
MPD remaining and We/'ll er cells (tife span 15 MPD) within 3 to 6 
MPD of termination. 
,. M ean ± SD. 
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in all normal and abnormal strains, but the differences betwee n 
these cells remained the same. Thus, higher levels of tiSsue 
factor in aging syndrome fibroblasts appear to be related to 
increased content rather than increased availability. Although 
we are unsure why ceUs from 2 geneticaUy different disorders 
show simiJaJ' elevations in tissue factor activity, the long-held 
concept of Rokitansky [41], who proposed that coagUlation 
mechanisms acting inwardly upon arterial walls contribute to 
atherosclerosis, is noteworthy. Plasma membranes of cells 
within the arterial intima and media layers appeal' to be rich in 
tissue factor antigen in both the large blood vessels and vaSa 
vasorum [42]. Moreover, tissue facto)' is also abundant in the 
vicinity of atheromatous plaques. It seems clear that this facto]' 
can initiate coagulation after plaque disruption or even after 
minimum cell damage. 
CONCLUSIONS 
Studies on cultured fibroblasts undergoing aging in vivo and 
in vitro give insight into several mechanisms of age-dependent 
disease. Senescent cell dropout may be the underlying basis fOl' 
the observed depletion of stem cell compartments in poorly 
renewable systems in vivo. A contracted cell mass would have 
a reduced functional capacity, and we speculate that pancreatic 
f3 cell dJ'opout frequently occurs in insulin-dependent diabetes 
whether the inciting agent is a virus, a toxin, or even a geneti-
cally determined limitation of the regenerative response. Simi-
larly, premature cellular dropout in specific regions of the brain 
in both senile dementia and Huntington disease [43] may be 
related to new'onspecific defects in gene expression, suscepti-
bility to exogenous agents, or both. 
A progressively diminished responsiveness to insulin and 
related hormones occurs during aging in vitro, and this phenom-
enon appears to be correlated with the rising incidence of 
diabetes mellitus in aging populations [44]. Most people with 
maturity-onset diabetes do not lack insulin; indeed, their cir-
culating levels of this hormone are often higher than normal. 
The problem, certainly in the insulin resistance seen in progeria 
and Werner syndrome, appears to be a reduced responsiveness 
[45]. It is not improbable._that the growth defects in the fibro-
. blasts of progeria, Werner syndrome, diabetic, and prediabetic 
individuals are in great part due to the poor response of these 
fibroblasts to insulin and insulin-like serum factors in the 
growth medium. 
However, age-dependent changes are not always decremental 
since we and others have shown that epinephrine-induced rises 
in cyclic AMP concentration occur in aged fibroblasts at the 
same time that prostaglandin E, stimulation falls [35-37]. The 
divergent responses to these 2 hormones are not understood, 
but they are pl'obably mediated through mechanisms different 
from those of polypeptide hormones. Further studies should 
help illuminate the basis of aberrant responses to adrenergic 
hormones in the elderly as well as the idiosyncratic dl'Ug reac-
tions frequently observed. 
Finally, although tissue factor does not increase significantly 
in aged normal fibroblasts as it does in Werner and progeria 
fibroblasts, clonal heterogeneity must be borne in mind. One 
need only postulate a small patch of aged vascu lar cells in the 
arterial or venous tree capable of lead ing to an athel'Othrom-
botic event. Moreover, if acting in concert with the impaired 
clot retraction previously described [46,47], this important 
group of vascular degenerative diseases could emanate from the 
cellular fixed tissue compartment and would not have to arise 
solely as a consequence of abnormal circulating clotting factors. 
This system of cultured skin fibroblasts should playa central 
role in helping us unravel the mysteries of age-dependent 
d iseases and should lead to rational plans for prevention and 
therapy. 
I thank Calvin Harley, Elena Moerman and my many colleagues for 
their invaluable aid in these studies. 
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